The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Relay Therapeutics Inc shares valued at $434,511 were sold by Patel Sanjiv on Nov 03 ’25. At $7.00 per share, Patel Sanjiv sold 62,073 shares. The insider’s holdings dropped to 703,215 shares worth approximately $4.59 million following the completion of this transaction.
Also, Rahmer Peter sold 21,394 shares, netting a total of over 160,455 in proceeds. Following the sale of shares at $7.50 each, the insider now holds 337,469 shares.
Before that, Rahmer Peter had sold 19,135 shares from its account. In a trade valued at $139,494, the insider traded Relay Therapeutics Inc shares for $7.29 each. Upon closing the transaction, the insider’s holdings decreased to 19,135 shares, worth approximately $2.34 million.
Analysts at Wells Fargo started covering the stock with ‘”an Equal weight”‘ outlook in a report released in mid April. As of September 10, 2024, Jefferies has increased its “Hold” rating to a “Buy” for RLAY.
Analyzing RLAY Stock Performance
On last trading session, Relay Therapeutics Inc [NASDAQ: RLAY] plunged -0.31% to $6.53. The stock’s lowest price that day was $6.44, but it reached a high of $6.716 in the same session. During the last five days, there has been a drop of approximately -11.04%. Over the course of the year, Relay Therapeutics Inc shares have jumped approximately 11.62%. Shares of the company reached a 52-week high of $7.64 on 10/29/25 and a 52-week low of $1.77 on 04/07/25.
Support And Resistance Levels for Relay Therapeutics Inc (RLAY)
According to the 24-hour chart, there is a support level at 6.41, which, if violated, would cause prices to drop to 6.29. In the upper region, resistance lies at 6.68. The next price resistance is at 6.84. RSI (Relative Strength Index) is 51.86 on the 14-day chart, showing neutral technical sentiment.
Is Relay Therapeutics Inc subject to short interest?
Stocks of Relay Therapeutics Inc saw a sharp steep in short interest on 2025-10-15 dropping by -0.58 million shares to 21.93 million. Data from Yahoo Finance shows that the short interest on 2025-09-15 was 22.5 million shares. A decline of -2.63% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 12.78 of the overall float, the days-to-cover ratio (short ratio) decline to 12.78.
Which companies own the most shares of Relay Therapeutics Inc (RLAY)?
In terms of Relay Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 19 in the next 12 months, up nearly 190.08% from the previous closing price of $6.55. Analysts anticipate Relay Therapeutics Inc stock to reach 25 by 2025, with the lowest price target being 16. In spite of this, 8 analysts ranked Relay Therapeutics Inc stock as Buy at the end of 2025.
